用户名: 密码: 验证码:
Structure of the Catalytic Domain of Human Polo-like Kinase 1
详细信息    查看全文
文摘
Polo-like kinase 1 (Plk1) is an attractive target for the development of anticancer agents dueto its importance in regulating cell-cycle progression. Overexpression of Plk1 has been detected in avariety of cancers, and expression levels often correlate with poor prognosis. Despite high interest inPlk1-targeted therapeutics, there is currently no structure publicly available to guide structure-based drugdesign of specific inhibitors. We determined the crystal structures of the T210V mutant of the kinasedomain of human Plk1 complexed with the nonhydrolyzable ATP analogue adenylylimidodiphosphate(AMPPNP) or the pyrrolo-pyrazole inhibitor PHA-680626 at 2.4 and 2.1 Å resolution, respectively.Plk1 adopts the typical kinase domain fold and crystallized in a conformation resembling the activestate of other kinases. Comparison of the kinetic parameters determined for the (unphosphorylated)wild-type enzyme, as well as the T210V and T210D mutants, shows that the mutations primarily affectthe kcat of the reaction, with little change in the apparent Km for the protein or nucleotide substrates (kcat= 0.0094, 0.0376, and 0.0049 s-1 and Km(ATP) = 3.2, 4.0, and 3.0 M for WT, T210D, and T210V,respectively). The structure highlights features of the active site that can be exploited to obtain Plk1-specific inhibitors with selectivity over other kinases and Plk isoforms. These include the presence of aphenylalanine at the bottom of the ATP pocket, combined with a cysteine (as opposed to the morecommonly found leucine) in the roof of the binding site, a pocket created by Leu132 in the hinge region,and a cluster of positively charged residues in the solvent-exposed area outside of the adenine pocketadjacent to the hinge region.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700